Researchers at Texas A&M have developed a method that uses nanoparticles to increase the production of mitochondria in stem cells. These stem cells produce up to twice as many mitochondria compared to their normal state. The excess mitochondria are then transferred into the weakened cells, increasing their ability to produce energy and resilience. This approach circumvents some of the limitations of current mitochondrial therapies. The method may have long-lasting effects and offers new treatment options for aging tissues. The results suggest potential for the treatment of several degenerative diseases. The study shows that increased mitochondrial production in stem cells can promote regeneration of damaged cells.